Adaptogens are a functional category of plants and fungi defined by three pharmacological criteria: (1) they are non-specific in action — they must increase resistance to a broad range of biological, chemical, and physical stressors; (2) they must normalize physiological function (both activating underactive and calming overactive systems); (3) they must be non-toxic at therapeutic doses. The concept was formalized by Soviet pharmacologist Nikolai Lazarev in 1947 and expanded by Brekhman and Dardymov through studies of Siberian ginseng (eleuthero) on military personnel and athletes. The mechanism of modern interest is primarily HPA axis modulation — reducing the magnitude and prolonging the recovery of the cortisol stress response.
Ashwagandha (Withania somnifera) is the most clinically studied adaptogen in Western research, with the strongest RCT evidence base. Rhodiola rosea has the best acute fatigue and burnout evidence. Panax ginseng has the longest historical use and broadest traditional evidence base. The key clinical distinction is that adaptogens do not sedate or stimulate directly — they buffer the stress response, reducing cortisol peak and accelerating return to baseline. This is mechanistically distinct from anxiolytics (GABA-A agonists like benzodiazepines) and stimulants (catecholamine release agents like caffeine).
| Adaptogen | Primary Mechanism | Best Evidence For | Evidence Quality | Standard Dose | Key Caveat |
|---|---|---|---|---|---|
| Ashwagandha (KSM-66) | HPA axis modulation; cortisol reduction; GABAergic activity (withanolides) | Chronic stress, anxiety, testosterone in men, sleep quality | Strong — multiple RCTs, N>50 | 300mg 2×/day with meals | Thyroid interaction (increases T3/T4); avoid in hyperthyroidism; rare liver injury cases reported with high doses |
| Rhodiola rosea (SHR-5) | AMPK activation; monoamine oxidase inhibition; cortisol blunting during acute stress | Acute mental fatigue, burnout, exercise performance | Good — several RCTs, best acute fatigue evidence of any adaptogen | 200–400mg (3% rosavins/1% salidroside) on empty stomach | Take in morning — stimulating effect disrupts sleep if taken late; may interact with SSRIs (serotonin syndrome risk at high doses) |
| Panax ginseng | Ginsenoside Rb1/Rg1 regulation of HPA axis; NO synthesis (cardiovascular); immune modulation | Cognitive performance, immune function, sexual function (erectile dysfunction modest evidence) | Moderate — many trials but inconsistent extract standardization; KRG (Korean red ginseng) has better evidence than other forms | 200–400mg (standardized to 5–7% ginsenosides) | Stimulating — avoid in anxiety or insomnia; 8-week cycling recommended (avoid continuous use >3 months); blood pressure interactions |
| Eleuthero (Siberian ginseng) | Eleutherosides modulate stress hormones; immune modulation; physical endurance | Physical endurance, immune support during high-stress periods; original Soviet military research target | Moderate — substantial historical evidence, fewer modern RCTs than ashwagandha or rhodiola | 300–1200mg root extract daily | Not a true ginseng (no ginsenosides); stimulating; avoid in hypertension; least-studied in modern trials |
| Schisandra chinensis | Schisandrins increase mitochondrial efficiency; hepatoprotective; cortisol normalization | Liver function, mental endurance under sustained load, physical fatigue | Weak-to-moderate — good traditional evidence; limited Western RCTs; stronger evidence for liver support than stress | 500–2000mg standardized extract | Weakest acute effect of major adaptogens; strongest synergistic effect when combined with rhodiola; hepatoprotection is its best-documented human effect |
| Sensoril ashwagandha | Same as KSM-66 but higher withanolide concentration (10%); more sedating due to leaf-sourced withanolides | Sleep, anxiety (stronger sedating effect than KSM-66) | Good — fewer RCTs than KSM-66 but solid anxiety/sleep data | 125–250mg/day (lower dose due to higher concentration) | More sedating than KSM-66 — better for sleep/anxiety applications; KSM-66 better for daytime use and testosterone/performance |
Chronic stress + anxiety + sleep: Ashwagandha KSM-66 300mg with breakfast + 300mg with dinner; or Sensoril 250mg with dinner only (more sedating, better for sleep-focused use); give 4–6 weeks minimum to assess effect (HPA axis normalization is a slow process); pair with magnesium glycinate 400mg at bedtime (additive sleep benefit via GABA-A modulation).
Acute mental fatigue + cognitive performance: Rhodiola rosea SHR-5 200–400mg on empty stomach 30 minutes before cognitively demanding work; effect is detectable within 30 minutes (AMPK and monoamine mechanism is faster than HPA normalization); can be taken 5 days on / 2 days off to avoid tolerance; do not take after 2pm (sleep disruption risk).
Athletic performance + testosterone (men): Ashwagandha KSM-66 300mg twice daily + resistance training 3×/week; testosterone signal requires both supplementation and training; give 8+ weeks to see hormonal changes (Wankhede protocol); can stack with zinc (cofactor for LH → testosterone conversion) and vitamin D (VDR regulates testosterone synthesis).
Cycling and stack considerations: Ashwagandha and rhodiola can be taken simultaneously; ashwagandha is better for evening use, rhodiola for morning; Panax ginseng should be cycled (8 weeks on, 4 weeks off); do not combine Panax ginseng with SSRIs without physician guidance; monitor thyroid labs (TSH, T3, T4) if using ashwagandha long-term, especially if on thyroid medication.
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.